NUCYNTA® ER (Tapentadol Extended-Release Tablets) Receives FDA Approval for the Management of Moderate to Severe …
Methadone Withdrawal: NUCYNTA® ER (Tapentadol Extended-Release Tablets) Receives FDA Approval for the Management of Moderate to Severe …
Janssen Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration has approved NUCYNTA® ER, an oral analgesic taken twice daily, for the management of moderate to severe chronic pain in adults when a continuous, around-the-clock opioid analgesic is needed for an extended period of time.
Methadone+ Withdrawal – Yahoo! News Search Results
More Methadone Withdrawal Information…